Protocol: hcunliffe10-032
PRIVILEGED COMMUNICATION FOR INVESTIGATIONAL USE ONLY
MEDICAL HISTORY FORM
Barcode will be completed by TGen Form Completed By SCCO Patient Family Member (please specify relationship) ______________________________
At date of completion of this form, patient is:
Alive Deceased date of death _____/_____/_____
1. Symptoms prior to diagnosis of SCCO
1a. First diagnosed with Small Cell Carcinoma of the Ovary (SCCO)
Date of diagnosis _____/______/_________
1b. Describe the physical symptoms experienced prior to diagnosis of SCCO (check all the apply)
Urinary symptoms (increased urgency and frequency)
Difficulty with eating or feeling full quickly
Pressure or pain in the back or legs
Other. Explain: _____________________________________________________________________
Other. Explain: _____________________________________________________________________
Other. Explain: _____________________________________________________________________
1c. How long did patient experience some or all of these symptoms before diagnosis? ____ yrs____ months
2. Patient History of Cancer
2a. Was there a diagnosis and treatment for any other type of cancer before diagnosis of SCCO?
complete below: (Check here anduse reverse for more space.)
Type: _______________________ Date: ______/_____/_________
Details: _______________________________________________________________________________
Type: _______________________ Date: ______/_____/_________
Protocol: hcunliffe10-032
PRIVILEGED COMMUNICATION FOR INVESTIGATIONAL USE ONLY
MEDICAL HISTORY FORM
Details: _______________________________________________________________________________
Comments: _______________________________________________________________________________
_________________________________________________________________________________________
2b. Was a genetic test performed to determine whether patient had an abnormality in either the BRCA1 gene or
Check here if BRCA1 mutation test was positive
Check here if BRCA2 mutation test was positive
2c. Were other genetic or DNA tests performed to evaluate possible genetic alterations for this patient?
Explain: (Check here anduse reverse for more space.)_______________________ __________________________________________________________________________________ 3. Patient Family History of Cancer (First-Degree Relatives)
3. Do any of the patient’s first-degree relatives, for example, parents, siblings, or children have a history of
If yes, complete all below. (Check here anduse reverse for more space.)
Relative 1: _______________ Cancer type: ___________________ Age at Diagnosis if known: _____ Details: _______________________________________________________________________________
_____________________________________________________________________________________ Relative 2: ______________ Cancer type: ___________________ Age at Diagnosis if known: _____ Details: _______________________________________________________________________________
_____________________________________________________________________________________ Relative 3: _______________ Cancer type: ___________________ Age at Diagnosis if known: _____ Details: _______________________________________________________________________________
_____________________________________________________________________________________
Check here if additional first-degree relatives have a history of cancer and use reverse. Continued on next page. 4. Patient Family History of Cancer (Second-Degree Relatives) Protocol: hcunliffe10-032
PRIVILEGED COMMUNICATION FOR INVESTIGATIONAL USE ONLY
MEDICAL HISTORY FORM
Barcode will be completed by TGen 4. Do any of the patient’s second-degree relatives, for example, grandparents, aunts, uncles, or cousins, have a
If yes, complete below: (Check here anduse reverse for more space.)
Paternal Cancer type: ______________ Age at Diagnosis if known: ____
Details: _______________________________________________________________________________
_____________________________________________________________________________________
Relative 2: ______________ Paternal Cancer type: ______________ Age at Diagnosis if known: ____
Details: _______________________________________________________________________________
_____________________________________________________________________________________
Relative 3: ______________ Paternal Cancer type: _______________ Age at Diagnosis if known: ____
Details: _______________________________________________________________________________
_____________________________________________________________________________________
Relative 4: ______________ Paternal Cancer type: _______________ Age at Diagnosis if known: ____
Details: _______________________________________________________________________________
_____________________________________________________________________________________
Check here if additional second-degree relatives have a history of cancer and use reverse.
5. Risk Factors - Hormonal
5a. What was the patient’s age at her first period (Menarche)?
Unknown Go to question 5c
How many children did patient give birth to?
How many miscarriages or abortions did patient have? ________
5c. What was patient’s menopausal status at time of diagnosis of SCCO: Unknown Unsure
Protocol: hcunliffe10-032
PRIVILEGED COMMUNICATION FOR INVESTIGATIONAL USE ONLY
MEDICAL HISTORY FORM Menstruation not yet started. No menopausal symptoms.Going through menopause* (see below for common symptoms)Menopausal symptoms have finished.
*Common symptoms of going through menopause (the beginning of menopausal symptoms typically occur in women ages 45-55 but some women show symptoms in their 30s.
• Changes in pattern of periods (can be shorter or longer, lighter or heavier, more or less time between periods)
• Hot flashes (sudden rush of heat in upper body)
• Night sweats (hot flashes that happen while you sleep), often followed by a chill
• Trouble sleeping through the night (with or without night sweats)
• Mood changes. Irritability. Trouble focusing, feeling mixed-up or confused,
• Hair loss or thinning on your head. More hair growth on your face
5d. Did patient use contraceptives for birth control at any time?
Did patient use hormonal contraceptives?
Does patient currently use hormonal contraceptives?
Did patient stop using hormonal contraceptives 10 or
5e. List any names or types and duration of contraceptives you recall were used by patient:
Currently Use Total Use in Years or Months
____ Years ____ Months Unknown
____ Years ____ Months Unknown
____ Years ____ Months UnknownIf known, names: _______________________________________________________________________ 6. Risk Factors – Lifestyle
6a. Did patient gain weight since turning 18 years of age and before diagnosis of SCCO?
Unknown Go to question 6b
What was the amount of weight gain (in pounds)?
6b. At the time of diagnosis, did patient smoke?
Protocol: hcunliffe10-032
PRIVILEGED COMMUNICATION FOR INVESTIGATIONAL USE ONLY
MEDICAL HISTORY FORM
Unknown Go to question 6c
Did patient smoke at any time previously?
Yes How long ago did patient quit? ___ Months or ___ Years Unknown
How long did patient smoke for? ___ Months or ___ Years Unknown
6c. At the time of diagnosis, did patient drink alcohol?
Average number of drinks: _____ per Day
7. Risk Factors – Other
7a. Did patient at any time have a diagnosis of one of the following? (check all that apply).
Kaposi's sarcoma-associated herpesvirus (KSHV)
7b. List all possible vaccinations you can recall for this patient and approximate year if known.
Vaccine: _________________________ year _______
Vaccine: _________________________ year _______
Vaccine: _________________________ year _______
Vaccine: _________________________ year _______
Check here and list additional vaccine information on reverse.
7b. Are there any unusual environmental exposures for the patient you would like to include?
For example, exposure to nuclear fallout or significant levels of radiation, work with toxic/carcinogenic substances, exposure to unusual pathogens, etc.
Describe: _____________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
Check here if additional details on environmental exposures and use reverse.
Protocol: hcunliffe10-032
PRIVILEGED COMMUNICATION FOR INVESTIGATIONAL USE ONLY
MEDICAL HISTORY FORM
Barcode will be completed by TGen 8. Treatment 8a. Did patient have surgery to remove the ovarian cancer? No Did patient receive chemotherapy or any other treatments to shrink the cancer?
Yes Date of Surgery (MM/DD/YYYY): ______/______/_______
Name of Doctor: __________________________________________
Hospital or clinic name: ____________________________________
Is a copy of the pathology report available?
Is a copy of the cytology report available?
Note: TGen will require a de-identified copy of the patient’s final pathology report(s) and cytology report (if cytology was requested by the surgeon). Patient personal identifying information can either be blanked out by you, or the TGen Research Coordinator will do this for you before it reaches the Researchers for this study.
8b. What chemotherapy did patient receive? (check all that apply):
Cisplatin (cisplatinum, or cis-diamminedichloroplatinum(II) or CDDP)
Cyclophosphamide (Endoxan, Cytoxan, Neosar, Procytox, Revimmune)
Doxorubicin (Adriamycin, hydroxydaunorubicin).
Etoposide (Eposin, Etopophos, Vepesid, VP-1)
Other________________________________
Other________________________________
Additional details: (Check here anduse reverse for more space.)______________________________
Protocol: hcunliffe10-032
PRIVILEGED COMMUNICATION FOR INVESTIGATIONAL USE ONLY
MEDICAL HISTORY FORM
Barcode will be completed by TGen 8c. Was there a diagnosis of ‘hypercalcemia’? Hypercalcemia is a high level of calcium in the blood.
If yes, did hypercalcemia symptoms (typically nausea and / or vomiting) lessen or disappear following
8d. Is (or was) patient receiving any other kind of treatment other than surgery and chemotherapy (like radiation)?
Unsure Go to question 8e Yes
Please explain, including dates of treatment: (Check here anduse reverse for more space.)
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
8e. Is (or was) patient receiving any other prescribed medications as part of her care?
complete below. (Check here anduse reverse for more space.)
Comments: _______________________________________________________________________________ _________________________________________________________________________________________
Protocol: hcunliffe10-032
PRIVILEGED COMMUNICATION FOR INVESTIGATIONAL USE ONLY
MEDICAL HISTORY FORM
Barcode will be completed by TGen 8f. Is (or was) patient diagnosed with any other medical conditions or co-morbidities? (examples listed below)
Connective tissue disease Diabetes type 1 or type 2
Diabetes with end organ damage type 1 or type 2 Lymphoma
Moderate or severe liver disease Any tumor (not ovarian cancer)
Yes complete below. (Check here anduse reverse for more space.) No Unknown NA
Comments: _______________________________________________________________________________ _________________________________________________________________________________________
Data Collection Form Receiving - To be completed by TGen staff:
Copy received at TGen by: _________________________________________ Date: ______/______/______
Comments: _______________________________________________________________________________
Vorträge im Naturkundehaus / 1.Halbjahr 2014 BN = Bund Naturschutz LBV = Landesbund für Vogelschutz TGN = Tiergarten der Stadt Nürnberg Donnerstag, 16. Januar 2014, 19.30 Uhr, Vortragssaal TGN Die Eingewöhnung unserer Tiere in Lagune und Manati-Haus Sarah Bucherer, Andreas Fackel, Lisa Kukuk, Christiane Thiere, Tiergarten Nürnberg In drei Einzelvorträgen geb
Material Safety Data Sheet Lithium Ion Cells and Battery Packs Section 1. Chemical Product and Company Identification PRODUCT IDENTIFICATION: Prismatic Lithium Ion Cells and Battery Packs MANUFACTURE’S NAME: EnerDel, Inc. EMERGENCY TELEPHONE NUMBER: INFOTRAC 800-535-5053 Environmental, Health and Safety Department Section 2. Composition/Information on Ingredients Batteries and